SCHEMBL5745185

SCHEMBL5745185

COC(=O)CN1C(=O)C(C)(Cc2ccccc2)Sc2cc(F)ccc21

nearest known ligand 0.47

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
POLB P06746 2/20 0.42
ALDH1A1 P00352 3/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.40
CASP3 P42574 1/20 0.40
OPRL1 P41146 4/20 0.39
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5745369 0.89 PTGDR2 (0.50) PTGDR2TP53
SCHEMBL5743757 0.88 ANPEP (0.47) LMNAPOLBPTGDR2TP53MAPT
SCHEMBL6847480 0.77 PPARG (0.54) LMNACASP3TP53
SCHEMBL10648774 0.64 PPARG (0.47) LMNAPOLBALDH1A1MAPT
SCHEMBL10512057 0.63 PTGDR2 (0.42) PTGDR2
SCHEMBL523176 0.63 CASP3 (0.55) LMNAPOLBALDH1A1CASP3MAPT
SCHEMBL4969017 0.62 NPSR1 (0.76) LMNAPOLBALDH1A1MAPT
SCHEMBL10650186 0.62 NPSR1 (0.70) LMNAPOLBALDH1A1MAPTPKM
SCHEMBL4969646 0.62 POLB (0.61) LMNAPOLBALDH1A1OPRL1
SCHEMBL16315850 0.62 TP53 (0.54) LMNAALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173427-B1 HYDROXAMIC ACID DERIVATIVE DAINIPPON SUMITOMO PHARMA CO (JP) 2006-04-05 EP disclosed
US-6713477-B1 1,4-BENZTHIAZINES OR BENZOXAZINES; MATRIX METALLOPROTEINASE INHIBITORS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-03-30 US disclosed
EP-1173427-A1 HYDROXAMIC ACID DERIVATIVE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2002-01-23 EP disclosed
WO-2000063197-A1 HYDROXAMIC ACID DERIVATIVE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2000-10-26 WO disclosed